Missed Opportunities for Pharmacist Intervention Among Medicare Fee-for-Service Beneficiaries With Myasthenia Gravis: A Real-world Claims Analysis

Synergistic Clinical Improvement in a Refractory AChR-positive Non-thymomatous Generalized Myasthenia Gravis Patient Treated With Concurrent Zilucoplan and Rozanolixizumab